MedTrace Logo

Scleroderma Registry

NCT00074568 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2022-09-27

No results posted yet for this study

Summary

Scleroderma is likely caused by a combination of factors, including an external trigger (infection or other exposure) and a genetic predisposition. The Scleroderma Registry will conduct genetic analyses for disease-related genes in patients with scleroderma and their family members (parents, brothers, and sisters).

Conditions

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    lead NIH

Principal Investigators

  • Maureen D. Mayes, MD, MPH · The University of Texas Health Science Center, Houston

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-09-30
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00074568 on ClinicalTrials.gov